Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Identification of small molecules targeting homoserine acetyl transferase from Mycobacterium tuberculosis and Staphylococcus aureus.
Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol.
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
Large-scale molecular epidemiological analysis of AAV in a cancer patient population.
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
See All 23 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Dasgupta I, Flotte TR, Keeler AM. CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing. Hum Gene Ther. 2021 03; 32(5-6):275-293.
View in:
PubMed
subject areas
CRISPR-Cas Systems
Endonucleases
Gene Editing
Gene Targeting
Humans
Prospective Studies
authors with profiles
Allison May Keeler-Klunk PhD
Terence R Flotte MD